Home >

ADIPSO’s VII International Congress Psoriasis: A medical and social problem

2012/07/02 - News from patients associations


VII International Congress

Psoriasis: A medical and social problem

Interaction among Patients, Dermatologists, Rheumatologists, General Practitioners, Psychologists, Nurses and Politicians

Promoted by A.DI.PSO.

Psoriasis is a disease with many different causes and characterised by erythematic-squamous lesions and a chronic and relapsing course. The disease may have different clinical pictures ranging from a small number of lesions to the involvement of all parts of the body. Moreover, there are some severe forms such as pustular psoriasis, erythrodermic psoriasis and psoriatic arthritis, which can be lifelong in some patients or, in the case of psoriatic arthritis, may be strongly invalidating.

The International Psoriasis Congress - A medical and social problem - has now reached its seventh edition and become an internationally relevant event. Promoted by A.DI.PSO. (The Italian Psoriasis Association), the Congress represents a great opportunity to make all those involved in the disease get together, namely: Patients, Dermatologists, Rheumatologists, General Practitioners, Psychologists, Nurses and Politicians.

All previous editions were attended by international experts as well as important Italian Institutional figures, such as all the Ministries of Health appointed during the years and with whom A.DI.PSO. has always collaborated to find solutions for the problem of Psoriasis and Psoriatic Arthritis.

During the Congress there were different presentations regarding the causes and the onset mechanisms of the disease as well as the clinical-diagnostic approach for both systemic and topic treatments, and, of course, news on the most recent discoveries. On the last day there was a round table in which patients will play an active role during the discussion of issues such as treatments with biologic drugs, which have brought very encouraging results and have proved to be a valid alternative to traditional treatments.

There were Italian experts - selected for their great experience in the field - that presented the results on the efficacy and tolerability of each biologic drug, and international experts who reported on their experience in the use of these drugs. Moreover, the congress reported on the results of recent genetic-molecular studies that demonstrate the genetic heterogeneity of this disease.

We have also involved Psychologists as psoriasis tends to be chronic, and thus has a strong psychological and social impact on people.

Most psoriatic patients tend to be anxious and/or depressed and have great difficulty in relating themselves with the community, with their partner, colleagues and friends. This disease can influence choices and bring doubts such as "can I have a partner? A family? Will my children have this disease?" all issues that may negatively influence the entire life of a psoriatic patient. That is why A.DI.PSO. has decided to dedicate space to studies aimed at evaluating the influence the disease has on the life and psychological wellbeing of patients as well as on the adherence to therapies in order to guarantee patients a global treatment and not just one limited to the disease itself.

The Congress was attended by representatives of Italian and European Psoriatic Patients Associations who reported on the results of questionnaires made on different issues related to the quality of life of psoriatic patients. The final part of the Congress was a round table with an interactive discussion among Italian and foreign Dermatologists, Rheumatologists, Psychologists and Patients. In order to give the opportunity to everyone to attend this discussion - also to those who cannot be physically present at the congress - the final day was broadcast live on the website of the Association www.adipso.org. Simultaneous translation from/to English was also included.

Click here to check out the Programme of the Congress.

SPIN Presentation

Newsletter

Follow us